Academic literature on the topic 'Arousal Disorder (FSIAD)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Arousal Disorder (FSIAD).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Arousal Disorder (FSIAD)"

1

Gold, LauraMaery. "Three Identified and Critiqued Measures of Sexuality." Communiqué: The Relationship Institute 1, no. 3 (2018): 1–5. https://doi.org/10.5281/zenodo.4672230.

Full text
Abstract:
Abstract: Female Sexual Interest/Arousal Disorder (FSIAD), a condition described in the DSM-5, can be quantified with available psychometric tools. Three measures of FSIAD are compared. Conclusions are drawn as to their relative merits.
APA, Harvard, Vancouver, ISO, and other styles
2

Höhle, Daniël, Kim van Rooij, Jos Bloemers, et al. "A survival of the fittest strategy for the selection of genotypes by which drug responders and non-responders can be predicted in small groups." PLOS ONE 16, no. 3 (2021): e0246828. http://dx.doi.org/10.1371/journal.pone.0246828.

Full text
Abstract:
Phenotype Prediction Scores (PPS) might be powerful tools to predict traits or the efficacy of treatments based on combinations of Single-Nucleotide Polymorphism (SNPs) in large samples. We developed a novel method to produce PPS models for small samples sizes. The set of SNPs is first filtered on those known to be relevant in biological pathways involved in a clinical condition, and then further filtered repeatedly in a survival strategy to select stabile positive/negative risk alleles. This method is applied on Female Sexual Interest/Arousal Disorder (FSIAD), for which two subtypes has been
APA, Harvard, Vancouver, ISO, and other styles
3

Elanjian, Alissa I., Sesilia Kammo, Lyndsey Braman, and Aron Liaw. "Advancing Women’s Health: A Scoping Review of Pharmaceutical Therapies for Female Sexual Dysfunction." Sexes 6, no. 3 (2025): 38. https://doi.org/10.3390/sexes6030038.

Full text
Abstract:
Background: Female Sexual Dysfunction (FSD) encompasses a range of conditions that can profoundly impact quality of life and intimate relationships. The primary classifications of FSD include female sexual interest and arousal disorder (FSIAD), genitopelvic pain and penetration disorder (GPPPD), female orgasmic disorder (FOD), and substance or medication-induced sexual dysfunction (SM-ISD). Despite its prevalence, FSD is often underdiagnosed and undertreated. Objectives: This scoping review follows Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to evalua
APA, Harvard, Vancouver, ISO, and other styles
4

Balon, R. "Diagnosis and Assessment of Female sexual Dysfunction(s)." European Psychiatry 24, S1 (2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70456-0.

Full text
Abstract:
The first challenge in diagnosing female sexual dysfunction(s) originates in our diagnostic system. The traditional model of classifying sexual dysfunction is anchored in the sexual response cycle: desire - arousal - orgasm - resolution. However, as some experts have pointed out, this classification may be problematic in the area of female sexuality. Both the diagnoses of female hypoactive sexual desire disorder (FHSDD) and female arousal disorder (FSAD) probably need to be redefined and refined. Examples include adding the lack of responsive desire to the FHSDD criteria and creating categorie
APA, Harvard, Vancouver, ISO, and other styles
5

Costabile, Raymond A., James G. McMurray, Gita Singh, Mitchell Wiatrak, and Craig Peterson. "738: Topical Alprostadil for the Treatment of Premenopausal Women with Female Sexual Arousal Disorder (FSAD)." Journal of Urology 173, no. 4S (2005): 201. http://dx.doi.org/10.1016/s0022-5347(18)35970-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Basson, Rosemary, Rosemary McInnes, Mike D. Smith, and Gemma Hodgson. "Efficacy & safety of viagra® in estrogenized women with sexual dysfunction associated with female sexual arousal disorder (FSAD)." International Journal of Gynecology & Obstetrics 70 (2000): E23. http://dx.doi.org/10.1016/s0020-7292(00)82403-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Impens, Ann Julie, and James R. Seibold. "Vascular Alterations and Sexual Function in Systemic Sclerosis." International Journal of Rheumatology 2010 (2010): 1–5. http://dx.doi.org/10.1155/2010/139020.

Full text
Abstract:
Sexual dysfunction is common in systemic sclerosis (SSc). Male erectile dysfunction (MED) has been reported in around 80% of subjects and more than half of female patients fulfill criteria for diagnosis as female sexual arousal Disorder (FSAD). While some evidence supports a role for cavernosal fibrosis, abundant data suggest that MED is yet another clinical feature of SSc related to vasculopathy. The contribution of vasculopathy to the more complex issues of female sexual dysfunction is less clear. Inhibitors of Type V phosphodiesterase are effective in men with MED secondary to SSc. Limited
APA, Harvard, Vancouver, ISO, and other styles
8

Rellini, Alessandra, and Cindy Meston. "ORIGINAL RESEARCH—OUTCOMES RESEARCH: The Sensitivity of Event Logs, Self‐Administered Questionnaires and Photoplethysmography to Detect Treatment‐Induced Changes in Female Sexual Arousal Disorder (FSAD) Diagnosis." Journal of Sexual Medicine 3, no. 2 (2006): 283–91. http://dx.doi.org/10.1111/j.1743-6109.2005.00153.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

PADMA-NATHAN, HARIN, CANDACE BROWN, JANE FENDL, SHAWKI SALEM, JAMES YEAGER, and RONALD HARNINGR. "Efficacy and Safety of Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD): A Double-Blind, Multicenter, Randomized, and Placebo-Controlled Clinical Trial." Journal of Sex & Marital Therapy 29, no. 5 (2003): 329–44. http://dx.doi.org/10.1080/00926230390224710.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lao, Q. P., M. Zhang, J. S. Bai, M. Y. Huang, J. Mo, and M. Lu. "Enhanced Effects of Specially Formulated Topical Alprostadil Cream by a Continuous Dosing Remedy for the Treatment of Female Sexual Arousal Disorder (FSAD) in a Double-Blind, Multicenter, Randomized, and Placebo-Controlled Clinical Trial." Fertility and Sterility 84 (September 2005): S131—S132. http://dx.doi.org/10.1016/j.fertnstert.2005.07.321.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Arousal Disorder (FSIAD)"

1

"Female Sexual Arousal Disorder (FSAD)." In Encyclopedia of Quality of Life and Well-Being Research. Springer Netherlands, 2014. http://dx.doi.org/10.1007/978-94-007-0753-5_101382.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

"Female Sexual Arousal Disorder (FSAD)." In Encyclopedia of Quality of Life and Well-Being Research. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-17299-1_301498.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Arousal Disorder (FSIAD)"

1

Rotmann, A. R., N. Mordhorst, and A. Kassen. "Damiana for the treatment of female sexual interest/arousal disorder (FSIAD) – Results of a multicentre non-interventional study." In GA – 69th Annual Meeting 2021, Virtual conference. Georg Thieme Verlag, 2021. http://dx.doi.org/10.1055/s-0041-1736810.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!